EXEVATE-G

Main information

  • Trade name:
  • EXEVATE-G 20G CRM
  • Dosage:
  • 0.64,1;MG;G
  • Pharmaceutical form:
  • CRM
  • Composition:
  • 20G
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • EXEVATE-G 20G CRM
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

There are no safety alerts related to this product.

29-5-2018

Osurnia (Elanco Europe Ltd)

Osurnia (Elanco Europe Ltd)

Osurnia (Active substance: terbinafine / florfenicol / betamethasone acetate) - Centralised - Yearly update - Commission Decision (2018)3406 of Tue, 29 May 2018

Europe -DG Health and Food Safety